CompletedPhase NAResults posted

Exendin-9,39 and Satiety After Bariatric Surgery

Lead sponsor

Mayo Clinic

Asset

Avexitide

Listed sites

Recruiting sites

Actual enrollment

Study population

Obesity / overweight

Eligibility highlights

•Healthy volunteers

Primary endpoint

Registered trial locations

Locations reported to ClinicalTrials.gov for this trial snapshot. Site count is not enrollment count; per-site enrollment is not available from source.

Identifiers

Registered as

NCT IDNCT02779075

Org study ID16-001973

Timeline

Milestones

Study first posted2016-05-20estimated

Last update posted2020-05-01actual

Results first posted2020-05-01actual

Study start2016-06 (month precision)

Primary completion2019-07actual (month precision)

Study completion2019-12actual (month precision)

Assets

Investigational agents

Avexitide

Who this study enrolls

Obesity / overweight

Who can enroll

Minimum age20 Years

Maximum age70 Years

SexAll

Healthy volunteersAccepted

Inclusion criteria

•Undergone either sleeve gastrectomy or Roux-en-Y Gastric Bypass surgery within prior 2 years

•Healthy, with no active systemic illness

Exclusion criteria

•Pregnancy

•Functional or organic bowel symptoms

•Systemic illness

•Diabetes

•Bariatric surgery > 2 years

Endpoints (0)

What's being measured

Protocol endpoints and posted registry outcome measures, grouped into outcome categories. Composite endpoints show their component event types. Standard codes (LOINC, SNOMED CT) are shown where available.

No endpoints recorded for this trial.

Provenance

Sources

Trial identity, design, statusClinicalTrials.gov API v2

Snapshot dateJuly 6, 2026

Endpoint classificationDelfa endpoint taxonomy v2 (May 13, 2026)

Results tableClinicalTrials.gov results section

Trial facts come from public ClinicalTrials.gov records. Endpoint categories are Delfa's classification of those records, not a ClinicalTrials.gov field. All figures reflect the July 6, 2026 snapshot.